This is a limited company view. Sign up for a Free Trial to see everything.

StemPar is developing a pipeline of powerful, first-in-class cancer drugs that attack solid tumors by simultaneously disrupting their

B2B
Biotechnology
Cleantech
Healthcare
Security
Solar Power

Overview

Location

Bay Area

Founded

2011

Employees

1

Stage

Unknown

Total funding

Undisclosed

Last funding

5 years ago

Acquisitions

0

Growth score

-5

Mindshare score

-4

Scoring

Deals

Undisclosed Amount Undisclosed Round

Troika Dialog

Jan 2, 2013

Employee Growth

Use StemPar Sciences's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use StemPar Sciences's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Director - Research

Similar Companies

AirGenerate

No Known Funding|2 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes